These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 33369)

  • 1. Studies on the mechanisms of central action of alpha-adrenergic receptor blocking agents.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1978; 30(4):455-8. PubMed ID: 33369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of prostaglandins F2alpha and E1.
    Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A
    Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between antidepressants and alpha-adrenergic receptor blocking agents.
    Zebrowska-Lupina I; Kozyrska C; Stelmasiak M
    Pol J Pharmacol Pharm; 1980; 32(5):673-80. PubMed ID: 6115370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE; Strömbom U
    Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
    Sawynok J; Reid A
    J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1976; 28(4):341-7. PubMed ID: 135973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of adenosine 3',5'-monophosphate formation in rat cerebral cortical slices by methoxamine: interaction with an alpha adrenergic receptor.
    Skolnick P; Daly JW
    J Pharmacol Exp Ther; 1975 May; 193(2):549-58. PubMed ID: 238025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of serotonin in the mechanism of central action of apomorphine.
    Grabowska M
    Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of alpha-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain.
    Zebrowska-Lupina I; Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):241-5. PubMed ID: 1713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha- and beta-adrenergic receptor blockers and the effects of noradrenaline on heat production and body temperature.
    Komáromi I
    Acta Physiol Hung; 1985; 65(2):155-67. PubMed ID: 2858957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
    Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
    Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
    Meltzer LT; Caprathe BW; Christoffersen CL; Corbin AE; Jaen JC; Ninteman FW; Pugsley TA; Serpa KA; Shih YH; Whetzel SZ
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1177-89. PubMed ID: 8103791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of alpha-adrenergic receptor stimulant drugs on amphetamine or apomorphine-induced stereotypy in rats.
    Zebrowska-Lupina I; Kleinrok Z; Kozyrska C; Wielosz M
    Pol J Pharmacol Pharm; 1978; 30(4):459-67. PubMed ID: 33370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central action of drugs acting on the cholinergic muscarinic receptor I. Influence of cholinomimetic drugs administered into the lateral cerebral ventricle on behavior in rats.
    Kleinrok Z; Wielosz M; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):465-75. PubMed ID: 1172419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.